Question: can otezla cause liver damage?
Answer: Since approval there have been no published reports of hepatotoxicity attributed to apremilast, but it has had limited clinical use. Because apremilast is immunosuppressive, it may cause reactivation of viral infections including hepatitis B, but such cases have not been reported.